Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Head and Neck CancerSquamous Cell Carcinoma
Interventions
DRUG

Zalutumumab

Eight weekly infusions

Trial Locations (8)

Unknown

St-Luc University Hospital, Brussels

Centre Georges-Francois Leclerc Hospital, Dijon

Medical Oncology, Outpatient Clinic, Nantes

Institut Claudius Regaud Toulouse, Toulouse

The Royal Marsden NHS Foundation Trust, London

Christie Hospital NHS Foundation Trust, Manchester

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

LS9 7TF

St James's Institute of Oncology, Leeds

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genmab

INDUSTRY